{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:02:04Z","timestamp":1773950524297,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03338-0","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:22:35Z","timestamp":1762874555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Solute carrier-correlated gene signature in predicting the prognosis and immunity in patients with acute myeloid leukemia"],"prefix":"10.1186","volume":"30","author":[{"given":"Delei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"3","key":"3338_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(3):502\u201326.","journal-title":"Am J Hematol"},{"issue":"5","key":"3338_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2174\/1566523223666230724121515","volume":"23","author":"Y Dong","year":"2023","unstructured":"Dong Y, Jin F, Wang J, Li Q, Huang Z, Xia L, et al. SFXN3 is associated with poor clinical outcomes and sensitivity to the hypomethylating therapy in non-M3 acute myeloid leukemia patients. Curr Gene Ther. 2023;23(5):410\u20138.","journal-title":"Curr Gene Ther"},{"issue":"2","key":"3338_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3324\/haematol.2022.280803","volume":"108","author":"RF Schlenk","year":"2023","unstructured":"Schlenk RF. Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges. Haematologica. 2023;108(2):306\u20137.","journal-title":"Haematologica"},{"issue":"1","key":"3338_CR4","first-page":"46","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, DiNardo CD, Kadia TM, Daver NG, Altman JK, Stein EM, et al. Acute myeloid leukemia management and research in 2025. CA Cancer J Clin. 2025;75(1):46\u201367.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3338_CR5","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","volume":"28","author":"AGX Zeng","year":"2022","unstructured":"Zeng AGX, Bansal S, Jin L, Mitchell A, Chen WC, Abbas HA, et al. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia. Nat Med. 2022;28(6):1212\u201323.","journal-title":"Nat Med"},{"key":"3338_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102308","author":"JH Park","year":"2020","unstructured":"Park JH, Pyun WY, Park HW. Cancer metabolism: phenotype, signaling and therapeutic targets. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9102308.","journal-title":"Cells"},{"issue":"1","key":"3338_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40364-024-00645-2","volume":"12","author":"LL Sun","year":"2024","unstructured":"Sun LL, He HY, Li W, Jin WL, Wei YJ. The solute carrier transporters (SLCs) family in nutrient metabolism and ferroptosis. Biomark Res. 2024;12(1):94.","journal-title":"Biomark Res"},{"key":"3338_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101952","volume":"84","author":"K Hushmandi","year":"2024","unstructured":"Hushmandi K, Einollahi B, Saadat SH, Lee EHC, Farani MR, Okina E, et al. Amino acid transporters within the solute carrier superfamily: underappreciated proteins and novel opportunities for cancer therapy. Mol Metab. 2024;84:101952.","journal-title":"Mol Metab"},{"issue":"4","key":"3338_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41594-024-01271-0","volume":"31","author":"S Newstead","year":"2024","unstructured":"Newstead S. Future opportunities in solute carrier structural biology. Nat Struct Mol Biol. 2024;31(4):587\u201390.","journal-title":"Nat Struct Mol Biol"},{"key":"3338_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040878","author":"JE Meg\u00edas-Vericat","year":"2022","unstructured":"Meg\u00edas-Vericat JE, Mart\u00ednez-Cuadr\u00f3n D, Solana-Altabella A, Poveda JL, Montesinos P. Systematic review of pharmacogenetics of ABC and SLC transporter genes in acute myeloid leukemia. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14040878.","journal-title":"Pharmaceutics"},{"key":"3338_CR11","doi-asserted-by":"publisher","first-page":"153303381989430","DOI":"10.1177\/1533033819894308","volume":"19","author":"B Lai","year":"2020","unstructured":"Lai B, Lai Y, Zhang Y, Zhou M, Sheng L, OuYang G. The solute carrier family 2 genes are potential prognostic biomarkers in acute myeloid leukemia. Technol Cancer Res Treat. 2020;19:1533033819894308.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"3338_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13148-022-01373-w","volume":"14","author":"Y Gu","year":"2022","unstructured":"Gu Y, Xu ZJ, Zhou JD, Wen XM, Jin Y, Yuan Q, et al. SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia. Clin Epigenet. 2022;14(1):162.","journal-title":"Clin Epigenet"},{"key":"3338_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.847624","volume":"13","author":"J Xie","year":"2022","unstructured":"Xie J, Chen L, Tang Q, Wei W, Cao Y, Wu C, et al. A necroptosis-related prognostic model of uveal melanoma was constructed by single-cell sequencing analysis and weighted co-expression network analysis based on public databases. Front Immunol. 2022;13:847624.","journal-title":"Front Immunol"},{"issue":"1","key":"3338_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cpan.2024.12.002","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang S, Liu K, Hu X, Gu X. Advances in drug discovery based on network pharmacology and omics technology. Curr Pharm Anal. 2024;21(1):33\u201343.","journal-title":"Curr Pharm Anal"},{"issue":"2","key":"3338_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.32604\/or.2023.028051","volume":"31","author":"W Bao","year":"2023","unstructured":"Bao W, Han Q, Guan X, Wang Z, Gu M. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma. Oncol Res. 2023;31(2):181\u201392.","journal-title":"Oncol Res"},{"issue":"1","key":"3338_CR16","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","volume":"11","author":"K Morita","year":"2020","unstructured":"Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, et al. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun. 2020;11(1):5327.","journal-title":"Nat Commun"},{"key":"3338_CR17","doi-asserted-by":"publisher","first-page":"E18761429380394","DOI":"10.2174\/0118761429380394250217093030","volume":"17","author":"S Yan","year":"2025","unstructured":"Yan S, Han Z, Wang T, Wang A, Liu F, Yu S, et al. Exploring the immune-related molecular mechanisms underlying the comorbidity of temporal lobe epilepsy and major depressive disorder through integrated data set analysis. Curr Mol Pharmacol. 2025;17:E18761429380394.","journal-title":"Curr Mol Pharmacol"},{"issue":"5","key":"3338_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"1","key":"3338_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13148-019-0730-1","volume":"11","author":"S Engebretsen","year":"2019","unstructured":"Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenet. 2019;11(1):123.","journal-title":"Clin Epigenet"},{"key":"3338_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.682002","volume":"9","author":"TT Liu","year":"2021","unstructured":"Liu TT, Li R, Huo C, Li JP, Yao J, Ji XL, et al. Identification of CDK2-related immune forecast model and ceRNA in Lung Adenocarcinoma, a pan-cancer analysis. Front Cell Dev Biol. 2021;9:682002.","journal-title":"Front Cell Dev Biol"},{"key":"3338_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7.","journal-title":"BMC Bioinform"},{"issue":"12","key":"3338_CR22","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1007\/s00277-024-06119-7","volume":"103","author":"T Bin","year":"2024","unstructured":"Bin T, Tang J, Lu B, Xu XJ, Lin C, Wang Y. Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi-associated genes. Ann Hematol. 2024;103(12):5297\u2013314.","journal-title":"Ann Hematol"},{"issue":"1","key":"3338_CR23","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1038\/s41598-024-59464-y","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang J, Wang H, Ding Y, Jiao X, Zhu J, Zhai Z. NET-related gene signature for predicting AML prognosis. Sci Rep. 2024;14(1):9115.","journal-title":"Sci Rep"},{"key":"3338_CR24","doi-asserted-by":"publisher","first-page":"1486592","DOI":"10.3389\/fimmu.2024.1486592","volume":"15","author":"FL Zhong","year":"2024","unstructured":"Zhong FL, He JJ, Bai KH, Shao RN, Wu GY, Tian XP, et al. Tigecycline-induced coagulation gene prognostic prediction model and intestinal flora signature in AML. Front Immunol. 2024;15:1486592.","journal-title":"Front Immunol"},{"issue":"4","key":"3338_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif). 2001;25(4):402\u20138.","journal-title":"Methods (San Diego, Calif)"},{"issue":"1","key":"3338_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12935-024-03592-y","volume":"24","author":"M Gao","year":"2024","unstructured":"Gao M, Wang M, Zhou S, Hou J, He W, Shu Y, et al. Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma. Cancer Cell Int. 2024;24(1):400.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"3338_CR27","first-page":"345","volume":"25","author":"J-H Kim","year":"2023","unstructured":"Kim J-H, Kim H-S, Lee S. BCL2L13 protein prevents apoptosis in acute myeloid leukemia cells. Oncologie. 2023;25(4):345\u201354.","journal-title":"Oncologie"},{"issue":"2","key":"3338_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1515\/oncologie-2023-0401","volume":"26","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Zhu F, Wang H, Lu F, Xue H. Treatment of central nervous system relapse in PLZF::RARA-positive acute promyelocytic leukemia by venetoclax combined with arubicin, cytarabine and intrathecal therapy: a case report. Oncologie. 2024;26(2):337\u201342.","journal-title":"Oncologie"},{"issue":"17","key":"3338_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36624","volume":"10","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhu H, Sheng Y, Cheng Z, Peng H. A novel prognostic model based on pyroptosis signature in AML. Heliyon. 2024;10(17):e36624.","journal-title":"Heliyon"},{"key":"3338_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.695865","volume":"12","author":"D Fu","year":"2021","unstructured":"Fu D, Zhang B, Wu S, Zhang Y, Xie J, Ning W, et al. Prognosis and characterization of immune microenvironment in acute myeloid leukemia through identification of an autophagy-related signature. Front Immunol. 2021;12:695865.","journal-title":"Front Immunol"},{"key":"3338_CR31","doi-asserted-by":"publisher","first-page":"1023040","DOI":"10.3389\/fonc.2022.1023040","volume":"12","author":"K Zhu","year":"2022","unstructured":"Zhu K, Lang Z, Zhan Y, Tao Q, Yu Z, Chen L, et al. A novel 10-gene ferroptosis-related prognostic signature in acute myeloid leukemia. Front Oncol. 2022;12:1023040.","journal-title":"Front Oncol"},{"issue":"1","key":"3338_CR32","first-page":"37","volume":"3","author":"SC Fagerholm","year":"2014","unstructured":"Fagerholm SC, Lek HS, Morrison VL. Kindlin-3 in the immune system. Am J Clin Exp Immunol. 2014;3(1):37\u201342.","journal-title":"Am J Clin Exp Immunol"},{"issue":"4","key":"3338_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3727\/096504020X15844389264424","volume":"28","author":"Y Qin","year":"2020","unstructured":"Qin Y, Wang Y, Liu D. MiR-4792 inhibits acute myeloid leukemia cell proliferation and invasion and promotes cell apoptosis by targeting Kindlin-3. Oncol Res. 2020;28(4):357\u201369.","journal-title":"Oncol Res"},{"issue":"1","key":"3338_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12882-023-03292-1","volume":"24","author":"S Hayward","year":"2023","unstructured":"Hayward S, Norton J, Bownass L, Platt C, Campbell H, Watson E, et al. A novel likely pathogenic CLCN5 variant in Dent\u2019s disease. BMC Nephrol. 2023;24(1):256.","journal-title":"BMC Nephrol"},{"key":"3338_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/112_2021_62","volume":"183","author":"U Banderali","year":"2022","unstructured":"Banderali U, Leanza L, Eskandari N, Gentile S. Potassium and chloride ion channels in cancer: a novel paradigm for cancer therapeutics. Rev Physiol Biochem Pharmacol. 2022;183:135\u201355.","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"6","key":"3338_CR36","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s12265-022-10274-5","volume":"15","author":"GE Xu","year":"2022","unstructured":"Xu GE, Song J, Gokulnath P, Vulugundam G, Xiao J. DUSP7: an unusual player in adverse cardiac remodeling. J Cardiovasc Transl Res. 2022;15(6):1217\u20138.","journal-title":"J Cardiovasc Transl Res"},{"key":"3338_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4348290","volume":"2023","author":"X Gao","year":"2023","unstructured":"Gao X. Identification of DUSP7 as an RNA marker for prognostic stratification in acute myeloid leukemia: evidence from large population cohorts. Genet Res. 2023;2023:4348290.","journal-title":"Genet Res"},{"issue":"1","key":"3338_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12672-024-01088-9","volume":"15","author":"C Zhao","year":"2024","unstructured":"Zhao C, Wang Y, Wang H, Sharma A, Wu Y, Schmidt-Wolf IGH, et al. Csrp1 gene: a potential novel prognostic marker in acute myeloid leukemia with implications for immune response. Discov Oncol. 2024;15(1):248.","journal-title":"Discov Oncol"},{"issue":"5","key":"3338_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/JCO.20.00475","volume":"39","author":"S Khaldoyanidi","year":"2021","unstructured":"Khaldoyanidi S, Nagorsen D, Stein A, Ossenkoppele G, Subklewe M. Immune biology of acute myeloid leukemia: implications for immunotherapy. J Clin Oncol. 2021;39(5):419\u201332.","journal-title":"J Clin Oncol"},{"key":"3338_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.833797","volume":"13","author":"A Jiang","year":"2022","unstructured":"Jiang A, Wang J, Liu N, Zheng X, Li Y, Ma Y, et al. Integration of single-cell RNA sequencing and bulk RNA sequencing data to establish and validate a prognostic model for patients with lung adenocarcinoma. Front Genet. 2022;13:833797.","journal-title":"Front Genet"},{"key":"3338_CR41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI159579","author":"S Rutella","year":"2022","unstructured":"Rutella S, Vadakekolathu J, Mazziotta F, Reeder S, Yau TO, Mukhopadhyay R, et al. Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI159579.","journal-title":"J Clin Invest"},{"key":"3338_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106727","volume":"111","author":"D Padmakumar","year":"2021","unstructured":"Padmakumar D, Chandraprabha VR, Gopinath P, Vimala Devi ART, Anitha GRJ, Sreelatha MM, et al. A concise review on the molecular genetics of acute myeloid leukemia. Leuk Res. 2021;111:106727.","journal-title":"Leuk Res"},{"issue":"6","key":"3338_CR43","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1182\/blood.2021013156","volume":"139","author":"CP Mill","year":"2022","unstructured":"Mill CP, Fiskus W, DiNardo CD, Birdwell C, Davis JA, Kadia TM, et al. Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2. Blood. 2022;139(6):907\u201321.","journal-title":"Blood"},{"issue":"10","key":"3338_CR44","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41375-022-01666-2","volume":"36","author":"R Ranieri","year":"2022","unstructured":"Ranieri R, Pianigiani G, Sciabolacci S, Perriello VM, Marra A, Cardinali V, et al. Current status and future perspectives in targeted therapy of NPM1-mutated AML. Leukemia. 2022;36(10):2351\u201367.","journal-title":"Leukemia"},{"issue":"12","key":"3338_CR45","doi-asserted-by":"publisher","first-page":"10015","DOI":"10.1007\/s00432-023-04884-y","volume":"149","author":"C Deng","year":"2023","unstructured":"Deng C, Zeng T, Zhu P, Zhao S, Huang Z, Huang W, et al. A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia. J Cancer Res Clin Oncol. 2023;149(12):10015\u201325.","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03338-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03338-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03338-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:04:16Z","timestamp":1762877056000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03338-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3338"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03338-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1107"}}